One Year of Exercise Boosts Natural GLP-1 Response by 37% — Potentially Replacing Drugs
52 weeks of exercise after diet-induced weight loss increased late-phase postprandial GLP-1 secretion by 37%, 25% more than usual activity (p=0.02), while liraglutide did not increase endogenous GLP-1.
Quick Facts
What This Study Found
Exercise increased late-phase postprandial GLP-1 by 37% within-group (p<0.001) and 25% vs usual activity (p=0.02). Liraglutide did not change endogenous GLP-1 response. Diet-induced weight loss did not alter GLP-1 (3%, NS).
Key Numbers
How They Did This
Exploratory analysis of 195 obese adults: LCD weight loss (-13.1 kg) → 52-week randomization to usual activity, exercise, liraglutide 3.0 mg, or combination. 3-h liquid meal test GLP-1 response measured.
Why This Research Matters
If exercise can boost natural GLP-1 by 37%, it provides a free, accessible way to maintain the hormonal benefits of weight loss — potentially reducing reliance on expensive GLP-1 drugs.
The Bigger Picture
Exercise may be the body's own GLP-1 agonist. This finding provides a biological mechanism explaining why exercise prevents weight regain.
What This Study Doesn't Tell Us
Exploratory analysis. Late-phase GLP-1 specifically. Cannot determine which exercise intensity/type optimizes GLP-1 response. Meal test may not perfectly replicate normal eating.
Questions This Raises
- ?Does the exercise-induced GLP-1 increase explain weight maintenance?
- ?Would higher exercise intensity produce greater GLP-1 enhancement?
- ?Can exercise + GLP-1 drugs produce additive appetite suppression?
Trust & Context
- Key Stat:
- 37% natural GLP-1 boost Exercise increased the body's own GLP-1 production by 37% after weight loss — potentially mimicking what GLP-1 drugs do pharmacologically
- Evidence Grade:
- Exploratory analysis from well-designed RCT. Novel finding for late-phase GLP-1 specifically, requiring confirmation.
- Study Age:
- Published in 2025, ClinicalTrials.gov NCT04122716.
- Original Title:
- One Year of Exercise After Weight Loss Increases Postprandial GLP-1 Secretion in Contrast to Usual Activity or GLP-1 Receptor Agonist Treatment.
- Published In:
- Obesity (Silver Spring, Md.), 34(1), 51-57 (2026)
- Authors:
- Holt, Joachim(2), Sandsdal, Rasmus Michael(3), Byberg, Sarah(2), Janus, Charlotte, Juhl, Christian Rimer, Jørgensen, Julie Rehné, Hartmann, Bolette, Stallknecht, Bente, Holst, Jens Juul, Madsbad, Sten, Jensen, Simon Birk Kjær, Torekov, Signe Sørensen
- Database ID:
- RPEP-15303
Evidence Hierarchy
Frequently Asked Questions
Can exercise boost your body's GLP-1?
Yes. One year of regular exercise increased natural GLP-1 production after meals by 37%. This is the same appetite-suppressing hormone that drugs like Ozempic mimic.
Does this mean exercise can replace GLP-1 drugs?
Not entirely replace, but exercise may reduce the need for high GLP-1 drug doses by naturally enhancing the body's own hormone production. The 37% increase is meaningful for appetite control.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15303APA
Holt, Joachim; Sandsdal, Rasmus Michael; Byberg, Sarah; Janus, Charlotte; Juhl, Christian Rimer; Jørgensen, Julie Rehné; Hartmann, Bolette; Stallknecht, Bente; Holst, Jens Juul; Madsbad, Sten; Jensen, Simon Birk Kjær; Torekov, Signe Sørensen. (2026). One Year of Exercise After Weight Loss Increases Postprandial GLP-1 Secretion in Contrast to Usual Activity or GLP-1 Receptor Agonist Treatment.. Obesity (Silver Spring, Md.), 34(1), 51-57. https://doi.org/10.1002/oby.70043
MLA
Holt, Joachim, et al. "One Year of Exercise After Weight Loss Increases Postprandial GLP-1 Secretion in Contrast to Usual Activity or GLP-1 Receptor Agonist Treatment.." Obesity (Silver Spring, 2026. https://doi.org/10.1002/oby.70043
RethinkPeptides
RethinkPeptides Research Database. "One Year of Exercise After Weight Loss Increases Postprandia..." RPEP-15303. Retrieved from https://rethinkpeptides.com/research/holt-2026-one-year-of-exercise
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.